Business context and reporting period
Camtek Ltd. filed an audited Form 20-F for the fiscal year ended December 31, 2011, prepared under U.S. GAAP. The company designs and sells automated optical inspection systems, semiconductor sample-preparation equipment, and digital material-deposition systems for semiconductor, PCB, and IC-substrate markets. This is an annual filing, not a standalone fourth-quarter report; it gives no clear Q4 revenue or profit figures. The auditor issued an unqualified opinion on the consolidated financial statements.
Key financial metrics
Amounts are U.S. dollars; financial statement figures are in millions unless stated otherwise.
| Metric | FY 2011 | FY 2010 |
|---|---|---|
| Revenue | $107.0 | $87.8 |
| Gross profit / margin | $47.4 / 44.3% | $38.4 / 43.8% |
| Operating income / margin | $9.0 / 8.4% | $4.9 / 5.5% |
| Net income | $5.4 | $2.8 |
| Basic / diluted EPS | $0.18 / $0.18 | $0.10 / $0.09 |
| Cash from operations | $9.8 | $(0.04) |
| Cash and cash equivalents | $22.2 | $9.6 |
| Short-term deposits | $4.1 | — |
| Working capital | $46.6 | $32.3 |
| Total assets | $104.8 | $96.3 |
| Total liabilities / equity | $44.8 / $59.9 | $42.3 / $54.0 |
Bank debt was $6.8 million at year-end 2011, comprising short-term loans and current and long-term portions of bank loans; the loans are secured by a lien on the Israeli facility and charges over assets. Capital expenditures were $1.2 million. Cash from investing activities was a use of $0.5 million, and financing activities provided $3.4 million.
Material changes versus prior period
- Revenue rose 22%; product sales increased 26% and service fees 6%. Microelectronics revenue increased to $57.7 million from $43.9 million, while PCB and IC-substrate revenue rose to $30.7 million from $26.4 million.
- Gross margin improved by 0.5 percentage points. Operating income nearly doubled; net income increased to $5.4 million from $2.8 million.
- Operating cash flow improved from near break-even to $9.8 million, while cash and cash equivalents increased by $12.6 million. Receivables declined, but inventory remained substantial at $26.3 million, including $2.0 million classified as long-term.
- Financial expense rose to $2.9 million from $1.5 million, mainly reflecting revaluation of acquisition-related contingent consideration and other liabilities. Inventory write-offs were $1.0 million versus $0.2 million in 2010.
- Asia Pacific generated about 80% of revenue. No individual customer accounted for more than 10% of annual revenue.
Outlook, risks, contingencies and unusual items
- Management reported that demand slowed in Q4 2011 and Q1 2012 amid global economic uncertainty, after improvement through the first three quarters of 2011. It provided no quantified revenue or earnings guidance, but expected existing resources and operating cash flows to meet liquidity needs through 2012.
- Key business risks include cyclical semiconductor and PCB markets, concentrated Asia-Pacific exposure, intense competition, long evaluation and sales cycles, inventory obsolescence, reliance on limited-source suppliers, and execution risk for new products, including Gannet, Xact200, Phoenix, and GreenJet. GreenJet remained in customer beta testing.
- Rudolph Technologies litigation remains significant. The appeals court vacated the original infringement finding, damages award, and injunction in the ’298 patent case and remanded it for a limited trial; the company estimated possible loss of $0–$12 million, excluding interest, and recorded no provision. A March 2012 order separately awarded $1.29 million in contempt damages, which Camtek intends to appeal; attorneys’ fees remain to be determined. Rudolph also filed a further patent complaint in December 2011, for which Camtek could not estimate potential loss.
- Camtek accrued approximately $2.25 million for a disputed legal-fee claim by Fish & Richardson. The Orbotech lawsuits were dismissed in 2011, and a securities class action was dismissed without leave to amend; no appeal was filed.
- An Israeli Office of the Chief Scientist dispute concerns approximately $0.7 million of additional royalties related to manufacturing moved abroad. Management assessed an unfavorable outcome as less than 50% likely and recorded no provision. The company also reported $5.4 million of unpaid grant obligations related to Camtek and Printar and $2.8 million related to Sela, including accrued interest.
- Year-end contractual obligations totaled $36.1 million, including $13.3 million of purchase commitments and $6.9 million of acquisition contingent consideration. Bank covenants were met at year-end. Management cautioned that additional financing may not be available on acceptable terms if liquidity proves insufficient.
- Foreign-exchange exposure includes net NIS-denominated liabilities of about $8.2 million; management estimated a 1% exchange-rate movement would affect results by approximately $82,000. The company uses currency options but does not apply hedge accounting.
Important facts for investors to verify
- Review subsequent developments and exposure in both Rudolph patent matters, including the contempt award, possible attorneys’ fees, and the newer patent complaint.
- Assess the persistence of the Q4 2011–Q1 2012 demand slowdown and whether management’s 2012 liquidity expectation was borne out.
- Examine inventory quality, the $1.0 million write-off, and the company’s ability to convert evaluation and demonstration systems into sales.
- Confirm compliance with loan covenants, debt repayment needs, collateral terms, and availability of cash across subsidiaries.
- Evaluate the OCS royalty dispute and obligations, acquisition-related contingent consideration, and related-party transactions with controlling shareholder Priortech.